Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 15, 2004
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
V Mahler, S Vrtala, O Kuss, et al.
International Journal of Immunopathology and Pharmacology
|
March 14, 2008
Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients
K Sonneck, C Baumgartner, L Rebuzzi, et al.
Allergo Journal International
|
June 30, 2015
Mites and other indoor allergens - from exposure to sensitization and treatment
Monika Raulf, K C Bergmann, S Kull, et al.
Allergy
|
January 11, 2018
Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivity
M Curin, T Garmatiuk, Y Resch-Marat, et al.
Allergy
|
February 21, 2012
Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients
K-W Chen, M Focke-Tejkl, K Blatt, et al.
International Archives of Allergy and Immunology
|
May 4, 1999
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy
S Vrtala, K Hirtenlehner, M Susani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 4, 1999
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7
V Niederberger, B Hayek, S Vrtala, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 12, 2007
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study
C Bussmann, L Maintz, J Hart, et al.
Allergy
|
January 10, 2018
Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
E Gadermaier, K Marth, C Lupinek, et al.
International Archives of Allergy and Immunology
|
August 7, 1998
The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases
R Valenta, S Almo, T Ball, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 15, 2004
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
V Mahler, S Vrtala, O Kuss, et al.
International Journal of Immunopathology and Pharmacology
|
March 14, 2008
Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients
K Sonneck, C Baumgartner, L Rebuzzi, et al.
Allergo Journal International
|
June 30, 2015
Mites and other indoor allergens - from exposure to sensitization and treatment
Monika Raulf, K C Bergmann, S Kull, et al.
Allergy
|
January 11, 2018
Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivity
M Curin, T Garmatiuk, Y Resch-Marat, et al.
Allergy
|
February 21, 2012
Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients
K-W Chen, M Focke-Tejkl, K Blatt, et al.
International Archives of Allergy and Immunology
|
May 4, 1999
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy
S Vrtala, K Hirtenlehner, M Susani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 4, 1999
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7
V Niederberger, B Hayek, S Vrtala, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
September 12, 2007
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study
C Bussmann, L Maintz, J Hart, et al.
Allergy
|
January 10, 2018
Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
E Gadermaier, K Marth, C Lupinek, et al.
International Archives of Allergy and Immunology
|
August 7, 1998
The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases
R Valenta, S Almo, T Ball, et al.
Page
of 8